Status:
COMPLETED
Preparation of Patients for Cardiac Surgery
Lead Sponsor:
Bayside Health
Collaborating Sponsors:
Griffith University
Conditions:
Coronary Artery Bypass Graft Surgery
Cardiac Valve Surgery
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
This was a prospective randomised trial of metabolic therapy including antioxidants and cellular energisers to determine whether this therapy could improve the results of cardiac surgery. The hypothes...
Detailed Description
Objective Perioperative therapy with antioxidants and metabolic substrates has the potential to reduce oxidative stress and improve recovery from cardiac surgery, particularly in elderly and high risk...
Eligibility Criteria
Inclusion
- patients undergoing elective coronary artery bypass graft (CABG) and/or valve surgery
Exclusion
- urgent or emergency surgery
- NYHA class IV heart failure
- taken antioxidant supplements in the previous month
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
117 Patients enrolled
Trial Details
Trial ID
NCT00906646
Start Date
April 1 2004
End Date
December 1 2008
Last Update
May 21 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Alfred Hospital
Melbourne, Victoria, Australia, 3004